In vitro activity of dirithromycin against Chlamydia trachomatis.
Dirithromycin is a new macrolide antibiotic with an active metabolite, erythromycylamine. We evaluated the in vitro activities of both drugs against 16 isolates of Chlamydia trachomatis and compared them with that of doxycycline. In vitro susceptibility testing was performed with McCoy cell monolaye...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1994
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284716/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7811051/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.9.2213 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
